Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunomodulatory Effects of Estrogen in Postmenopausal Women with Chronic Infections
NCT00001890Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- May 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DehydraTECH-estrogen in atherosclerosis, Chlamydia pneumoniae infection, cytomegalovirus infection (CMV), sponsored by National Heart, Lung, and Blood Institute. Started May 1999; status: completed.
02
Drugs
DehydraTECH-estrogen
03
Conditions
atherosclerosisChlamydia pneumoniae infectioncytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT00001890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001890.